Results 21 to 30 of about 1,700 (160)

Diffuse waxy papules and dermal mucin in skin of color: A case of scleromyxedema. [PDF]

JAAD Case Rep
Ajmani A, Klufas T, Zhou A, Berke A, Ferenczi K, Mallett J.   +5 more
europepmc   +2 more sources

Successful treatment of scleromyxedema with dupilumab: A case report. [PDF]

JAAD Case Rep
Alghamdi A, Alfawzan A, Aburas K, Ayoub N, Almohideb M.   +4 more
europepmc   +2 more sources

Clonal disorders of clinical significance. A concept with important therapeutic implications. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 891-892, May 2025.
Lipsker D.
europepmc   +2 more sources

Intravenous immunoglobulin in the treatment of scleromyxedema associated with monoclonal gammopathy. [PDF]

An Bras Dermatol
Perrella ACM, Michalany A, Pires MC, Lima CO.   +3 more
europepmc   +2 more sources

Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins. [PDF]

Front Immunol, 2022
Scleromyxedema is a rare idiopathic fibromucinous disorder characterized by a generalized papular and sclerodermoid cutaneous eruption. Patients often have praraproteinemia and extracutaneous, even lethal, manifestations.
Wang SS, Chen QY, Xiang LH.
europepmc   +2 more sources

Scleromyxedema and Breast-Implant Associated Lymphoma: Investigating an Unusual Clinical Association. [PDF]

Cureus
Scleromyxedema, a rare skin condition, is characterized by a waxy-appearing papular eruption that tends to impact middle-aged adults. Scleromyxedema is often linked to monoclonal gammopathies.
Cline E, Pitchford C, Brady J, Bari O, McBride JD.   +4 more
europepmc   +2 more sources

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Scleromyxedema (SM) is a rare primary cutaneous mucinosis characterized by systemic papules and scleroderma-like manifestations, often associated with monoclonal gammopathy.
Gao A, Tian X, Lang D, Chen Y.
europepmc   +2 more sources

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin. [PDF]

JAAD Case Rep, 2023
Zhang D, Sable K, Miller A, Hinshaw M, Schmidt T, Shields BE.   +5 more
europepmc   +2 more sources

Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. [PDF]

Cureus
Lichen myxedematosus (LM) is characterized by dermal mucin buildup, fibroblast proliferation, and variable presentation. The diffuse variant, known as scleromyxedema, is identified by monoclonal paraprotein presence and lack of thyroid issues, with ...
Peshin S, Modi SK, Burwick N.
europepmc   +2 more sources

Treatment of a Complex Case of Scleromyxedema Using a Novel Intravenous Immunoglobulin Preparation. [PDF]

Case Rep Dermatol
Introduction We provide a case report on a patient with scleromyxedema treated with high-dose intravenous immunoglobulins (IVIgs) who reported less fatigue and fewer headaches after transitioning to Yimmugo, a novel IVIg preparation.
Vollmer AS, Wiedenmayer N, Winkler JK, Enk AH.   +3 more
europepmc   +2 more sources